{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002381","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.803628+00:00","generated_at":"2026-05-28T04:50:51.817703+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeuroOne reports preliminary Q1 FY2025 revenue of $6.2M, up from $1.0M YoY","bullets":["Preliminary unaudited Q1 FY2025 total revenue $6.2M vs $1.0M in Q1 FY2024.","Includes $3.0M one-time collaboration revenue from Zimmer Biomet expanded distribution agreement.","Product revenue $3.2M, up 227% YoY from $1.0M.","Reiterates FY2025 product revenue guidance $8-10M, product gross margin 47-51%.","Virtual investor webinar held Jan 10, 2025 at 11am ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002381","json":"https://secwatch.observer/filing/0001213900-25-002381.json","markdown":"https://secwatch.observer/filing/0001213900-25-002381.md","text":"https://secwatch.observer/filing/0001213900-25-002381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/0001213900-25-002381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/ea0225131-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:50:51.817703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}